Therapeutic potential of Cordyceps militaris cultivated with Ginkgo biloba seeds for alleviating western diet-induced type 2 diabetes and diabetic nephropathy
- PMID: 40510419
- PMCID: PMC12158992
- DOI: 10.3389/fphar.2025.1562116
Therapeutic potential of Cordyceps militaris cultivated with Ginkgo biloba seeds for alleviating western diet-induced type 2 diabetes and diabetic nephropathy
Abstract
Background: Diabetic nephropathy (DN), a leading cause of chronic kidney disease and end-stage renal disease, is a serious complication of type 2 diabetes mellitus (T2DM). Current therapies primarily slow disease progression but are unable to reverse kidney damage, highlighting the need for novel therapy to treat DN.
Objective: This study evaluated the therapeutic potential of Cordyceps militaris (C. militaris) cultivated on Ginkgo biloba (G. biloba) seeds in ameliorating T2DM and its complications, especially DN. A T2DM mouse model was established using ApoE knockout mice fed a Western diet (WD).
Results: Treatment with the specially cultivated C. militaris ameliorated hyperglycemia, dyslipidemia and hepatic dysfunction, while mitigating T2DM-induced renal damage. Key biochemical markers, including blood glucose, triglycerides, cholesterol, blood urea nitrogen (BUN), and creatinine, were significantly improved after treatment. Histopathologic analysis revealed restored renal morphology, reduced fibrosis and decreased amyloid deposition. Mechanistic studies showed downregulation of fibrosis-related proteins such as α-SMA, COL1, TIMP-1, CTGF, TGFβ1 and fibronectin, and upregulation of E-cadherin, Smad7 and Klotho, proteins with anti-fibrotic and renoprotective properties.
Conclusion: These results suggest that the specially cultivated C. militaris enhances metabolic regulation and renal repair mechanisms, effectively attenuating T2DM-induced renal damage. This unique cultivation approach enriches the bioactive properties of C. militaris and offers a promising natural therapeutic strategy for T2DM and DN. Further studies are needed to validate these results in clinical settings and to explore long-term efficacy and safety.
Keywords: Cordyceps militaris; Ginkgo biloba seeds; diabetes mellitus; diabetic nephropathy; kidney.
Copyright © 2025 Lin, Kuo, Tsai, Paul, Kuo, Hsieh, Kao, Pai, Chen, Huang and Lin.
Conflict of interest statement
Author S-JC was employed by Home Run Biotechnology Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures








Similar articles
-
Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.J Ethnopharmacol. 2021 Dec 5;281:113548. doi: 10.1016/j.jep.2020.113548. Epub 2020 Nov 3. J Ethnopharmacol. 2021. PMID: 33152427
-
Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice.PLoS One. 2016 Nov 10;11(11):e0166342. doi: 10.1371/journal.pone.0166342. eCollection 2016. PLoS One. 2016. PMID: 27832180 Free PMC article.
-
Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy.Phytomedicine. 2015 Nov 15;22(12):1071-8. doi: 10.1016/j.phymed.2015.08.010. Epub 2015 Sep 6. Phytomedicine. 2015. PMID: 26547529
-
Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.Acta Pharm Sin B. 2021 Sep;11(9):2749-2767. doi: 10.1016/j.apsb.2020.12.020. Epub 2021 Feb 2. Acta Pharm Sin B. 2021. PMID: 34589395 Free PMC article. Review.
-
Can Cordyceps cicadae be used as an alternative to Cordyceps militaris and Cordyceps sinensis? - A review.J Ethnopharmacol. 2020 Jul 15;257:112879. doi: 10.1016/j.jep.2020.112879. Epub 2020 Apr 16. J Ethnopharmacol. 2020. PMID: 32305637 Review.
References
-
- Belwal T., Giri L., Bahukhandi A., Tariq M., Kewlani P., Bhatt I. D., et al. (2019). “Ginkgo biloba,” in Nonvitamin and nonmineral nutritional supplements. New York, NY, United States, Elsevier, 241–250.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous